US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment - Reuters
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment Reuters
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
Women who used estrogen-only hormone therapy later in life were less likely to develop dementia and showed fewer signs o…
Mount Sinai Advances as Milestone 2 Awardee in XPRIZE Healthspan, a $101 Million Global Competition Focused on Extending…
Leading Cancer Advocacy Organizations Back Proposition 38 To Advance Life-Saving Medical Research and Cures einpresswire…
Hong Kong Postnatal Care Ushers in a Breakthrough Era: "Anna Postnatal Care Center" Introduces Innovative Technique Achi…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →